Skip to main content
Mankind Pharma Limited logo

Mankind Pharma Limited — Investor Relations & Filings

Ticker · MANKIND ISIN · INE634S01028 LEI · 33580067G8AZ7S8NYA02 BSE.NS Manufacturing
Open in API
Filings indexed 397 across all filing types
Latest filing 2024-09-02 Investor Presentation
Country IN India
Listing BSE.NS MANKIND

About Mankind Pharma Limited

https://www.mankindpharma.com/

Mankind Pharma Limited focuses on the development, manufacturing, and marketing of a broad spectrum of pharmaceutical formulations and consumer healthcare products. The company’s portfolio spans various therapeutic areas, including anti-infectives, cardiovascular, gastrointestinal, dermatology, and respiratory health. It maintains a significant presence in the over-the-counter segment with brands such as Manforce, Prega News, and Gas-O-Fast. The organization operates a robust research and development infrastructure dedicated to creating affordable and accessible medicinal solutions. Its operational model leverages an extensive distribution network to ensure product availability across diverse geographic regions, prioritizing high-quality healthcare delivery and patient-centric innovation.

Recent filings

Filing Released Lang Actions
Updates
Investor Presentation Classification · 95% confidence The document is a detailed presentation addressed to stock exchanges and investors, containing company overview, history, strategy, acquisition rationale, financial highlights, and forward-looking statements. It explicitly mentions that it is a presentation for the information of investors and is uploaded on the company's website. The content includes strategic plans, acquisition details, market position, and financial metrics but does not contain full financial statements or detailed quarterly or annual financial reports. The document length is about 15,000 characters, which is typical for an investor presentation. There is no indication that this is an annual report, earnings release, or regulatory filing. The presence of slides, index, and forward-looking statements further supports classification as an investor presentation rather than a formal report or announcement. Therefore, the most appropriate classification is Investor Presentation (IP).
2024-09-02 English
Updates
Regulatory Filings Classification · 95% confidence The document is an intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It informs about a penalty order received by the company from a tax authority and the company's intention to appeal. The document is a regulatory announcement about a legal/penalty event, not a full report or financial statement. It is short (3571 characters) and serves as a disclosure of a material event as required by SEBI regulations. There is no financial data, no detailed report, no earnings or management discussion, and no shareholder meeting material. This fits best under Regulatory Filings (RNS), which is the fallback category for such regulatory announcements and compliance disclosures that do not fit other categories.
2024-08-26 English
Updates
Regulatory Filings Classification · 95% confidence The document is an intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It informs about a penalty order received from a tax authority and the company's intention to appeal. The document is a regulatory announcement about a legal/penalty event, not a full audit report, annual report, or financial statement. It is a disclosure of a material event as required by SEBI regulations, fitting the category of Regulatory Filings (RNS). The document length is short (3420 characters) and it does not contain financial statements or detailed financial analysis, so it is not an Annual Report or Audit Report. It is not a report publication announcement since it contains the full disclosure text. Therefore, the best classification is Regulatory Filings (RNS).
2024-08-26 English
Updates
Investor Presentation Classification · 100% confidence The document is a presentation titled 'INVESTOR PRESENTATION Aug-2024' by Mankind Pharma Limited, submitted pursuant to SEBI regulations. It includes detailed slides on company strategy, market share, product portfolio, growth plans, and financial highlights. The text references an investor conference and the presentation is uploaded on the company's website. There are no financial statements or detailed financial analysis typical of annual or quarterly reports. The document is not a brief announcement or a certification letter but a detailed presentation aimed at investors. Therefore, it fits the category of an Investor Presentation (IP).
2024-08-20 English
Allotment of Securities
Share Issue/Capital Change Classification · 95% confidence The document is a formal notification addressed to stock exchanges regarding the allotment of 9,000 equity shares under the company's Employee Stock Option Plan 2022. It references compliance with SEBI regulations related to share-based employee benefits. The content focuses on the issuance of shares, details of the allotment, and the resulting change in paid-up share capital. There is no financial performance data, management discussion, or report attached. The document is an announcement of a capital change due to share allotment under ESOP, which fits the category of Share Issue/Capital Change filings.
2024-08-14 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice informing stock exchanges about the company's participation in an upcoming investor conference. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of events or information. The document explicitly states that no unpublished price sensitive information will be shared and is intended for information and records. There are no financial statements, detailed financial data, or report attachments. The length is only 1295 characters, indicating it is a brief announcement rather than a full report or presentation. This fits the category of a Regulatory Filing (RNS), which covers general regulatory announcements and compliance disclosures that do not fit other specific categories.
2024-08-13 English

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.